All 6 insiders bought on Aug 10 — a single shared event.
- Gordon Carl LDirector$10M
- Orbimed Advisors LlcDirector$10M
- Chen BihuaDirector, 10% Owner$5M
- Schmid John P.Director$96K
- Liptak Vincent PaulGeneral Counsel$74.7K
Insider trading activity for BlossomHill Therapeutics, Inc., straight from SEC Form 4 filings. Net figures below count open-market buys and sales only — grants, option exercises and tax withholding are excluded because they are compensation, not decisions to trade.
6 insiders bought on the open market within 30 days.
All 6 insiders bought on Aug 10 — a single shared event.
The 43 most recent Form 4 transactions.
How quickly insiders here report their trades. Section 16 allows two business days from the transaction.
All 10 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
Everyone who has filed a Form 4 for this issuer.